Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Henderson Biotech Innovation Master Fund Ltd Janus currently holds 2,117,213 shares of ARCA biopharma, Inc. (ABIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Henderson Biotech Innovation Master Fund Ltd Janus has been a net buyer of ABIO stock. They have purchased $1.4M and sold $0 worth of shares.
Henderson Biotech Innovation Master Fund Ltd Janus's most recent insider trade was on Aug 16, 2024, when they purchased 428 shares at $2.98 per share.
Henderson Biotech Innovation Master Fund Ltd Janus serves as Executive at ARCA biopharma, Inc. (ABIO). They have executed 11 insider transactions totaling $1.4M over their tenure at the company.
Henderson Biotech Innovation Master Fund Ltd Janus holds the position of Executive at ARCA biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Henderson Biotech Innovation Master Fund Ltd Janus has shown a buying trading pattern, with $1.4M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Henderson Biotech Innovation Master Fund Ltd Janus was on Jul 3, 2024, when they purchased $589.4K worth of ABIO shares. This transaction involved 166,042 shares at $3.55 per share.
Henderson Biotech Innovation Master Fund Ltd Janus currently owns 2,117,213 shares of ARCA biopharma, Inc. (ABIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Henderson Biotech Innovation Master Fund Ltd Janus's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Henderson Biotech Innovation Master Fund Ltd Janus has 11 Form 4 filings on record as an insider at ARCA biopharma, Inc..
Set alerts for Henderson Biotech Innovation Master Fund Ltd Janus and 40,000+ other insiders.